Literature DB >> 23065790

Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.

J A Schneider1, Z Arvanitakis, L Yu, P A Boyle, S E Leurgans, D A Bennett.   

Abstract

Lewy bodies are common in the ageing brain and often co-occur with Alzheimer's disease pathology. There is little known regarding the independent role of Lewy body pathology in cognition impairment, decline and fluctuations in community-dwelling older persons. We examined the contribution of Lewy body pathology to dementia, global cognition, cognitive domains, cognitive decline and fluctuations in 872 autopsied subjects (mean age = 87.9 years) from the Rush Religious Order Study (n = 491) and Memory and Aging Project (n = 381) longitudinal community-based clinical-pathological studies. Dementia was based on a clinical evaluation; annual cognitive performance tests were used to create a measure of global cognition and five cognitive domains. Lewy body type was determined by using α-synuclein immunostained sections of substantia nigra, limbic and neocortical regions. Statistical models included multiple regression models for dementia and cognition and mixed effects models for decline. Cognitive fluctuations were estimated by comparing standard deviations of individual residuals from mean trajectories of decline in those with and without Lewy bodies. All models controlled for age, sex, education, Alzheimer's disease pathology and infarcts. One hundred and fifty-seven subjects (18%) exhibited Lewy body pathology (76 neocortical-type, 54 limbic-type and 27 nigra-predominant). One hundred and three (66%) subjects with Lewy body pathology had a pathologic diagnosis of Alzheimer's disease. Neocortical-type, but not nigral-predominant or limbic-type Lewy body pathology was related to an increased odds of dementia (odds ratio = 3.21; 95% confidence interval = 1.78-5.81) and lower cognition (P < 0.001) including episodic memory function (P < 0.001) proximate to death. Neocortical-type Lewy body pathology was also related to a faster decline in global cognition (P < 0.001), decline in all five specific cognitive domains (all P-values < 0.001), and to fluctuations in decline of working and semantic memory (P-values < 0.001). Limbic-type Lewy body pathology was related to lower and faster decline in visuospatial skills (P = 0.042). The relationship of Lewy body pathology to cognition and dementia was not modified by Alzheimer's disease pathology. Neocortical-type Lewy body pathology is associated with increased odds of dementia; lower and more rapid decline in all cognitive domains including episodic memory and fluctuations in decline in semantic and working memory. Limbic-type Lewy body pathology is specifically associated with lower and more rapid decline in visuospatial skills. The effect of Lewy body pathology on cognition appears to be independent of Alzheimer's disease pathology.

Entities:  

Mesh:

Year:  2012        PMID: 23065790      PMCID: PMC3470712          DOI: 10.1093/brain/aws234

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  51 in total

1.  The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease.

Authors:  C Ballard; J O'Brien; C M Morris; R Barber; A Swann; D Neill; I McKeith
Journal:  Int J Geriatr Psychiatry       Date:  2001-05       Impact factor: 3.485

2.  Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study.

Authors:  Lon White; Brent J Small; Helen Petrovitch; G Webster Ross; Kamal Masaki; Robert D Abbott; John Hardman; Daron Davis; James Nelson; William Markesbery
Journal:  J Geriatr Psychiatry Neurol       Date:  2005-12       Impact factor: 2.680

3.  Rapidly progressive dementia in a patient with the Lewy body variant of Alzheimer's disease.

Authors:  T P Armstrong; L A Hansen; D P Salmon; E Masliah; M Pay; J M Kunin; R Katzman
Journal:  Neurology       Date:  1991-08       Impact factor: 9.910

4.  The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity.

Authors:  L Hansen; D Salmon; D Galasko; E Masliah; R Katzman; R DeTeresa; L Thal; M M Pay; R Hofstetter; M Klauber
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

5.  Microinfarct pathology, dementia, and cognitive systems.

Authors:  Zoe Arvanitakis; Sue E Leurgans; Lisa L Barnes; David A Bennett; Julie A Schneider
Journal:  Stroke       Date:  2011-01-06       Impact factor: 7.914

6.  Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.

Authors:  M L Kraybill; E B Larson; D W Tsuang; L Teri; W C McCormick; J D Bowen; W A Kukull; J B Leverenz; M M Cherrier
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

7.  Diffuse Lewy body disease: clinical features in 15 cases.

Authors:  E J Byrne; G Lennox; J Lowe; R B Godwin-Austen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

8.  Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology.

Authors:  J A Schneider; R S Wilson; J L Bienias; D A Evans; D A Bennett
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

9.  Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.

Authors:  D A Bennett; R S Wilson; J A Schneider; D A Evans; N T Aggarwal; S E Arnold; E J Cochran; E Berry-Kravis; J L Bienias
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

10.  Individual differences in rates of change in cognitive abilities of older persons.

Authors:  Robert S Wilson; Laurel A Beckett; Lisa L Barnes; Julie A Schneider; Julie Bach; Denis A Evans; David A Bennett
Journal:  Psychol Aging       Date:  2002-06
View more
  110 in total

1.  Association of APOE with tau-tangle pathology with and without β-amyloid.

Authors:  Jose M Farfel; Lei Yu; Philip L De Jager; Julie A Schneider; David A Bennett
Journal:  Neurobiol Aging       Date:  2015-09-28       Impact factor: 4.673

2.  Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology.

Authors:  Hyun-Sik Yang; Charles C White; Hans-Ulrich Klein; Lei Yu; Christopher Gaiteri; Yiyi Ma; Daniel Felsky; Sara Mostafavi; Vladislav A Petyuk; Reisa A Sperling; Nilüfer Ertekin-Taner; Julie A Schneider; David A Bennett; Philip L De Jager
Journal:  Neuron       Date:  2020-06-10       Impact factor: 17.173

3.  Conscientiousness, dementia related pathology, and trajectories of cognitive aging.

Authors:  Robert S Wilson; Patricia A Boyle; Lei Yu; Eisuke Segawa; Joel Sytsma; David A Bennett
Journal:  Psychol Aging       Date:  2015-02-09

4.  Disturbed sleep in preclinical cognitive impairment: cause and effect?

Authors:  Bryce A Mander
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

Review 5.  Defining Cognitive Reserve and Implications for Cognitive Aging.

Authors:  Corinne Pettigrew; Anja Soldan
Journal:  Curr Neurol Neurosci Rep       Date:  2019-01-09       Impact factor: 5.081

6.  Financial and Health Literacy Predict Incident Alzheimer's Disease Dementia and Pathology.

Authors:  Lei Yu; Robert S Wilson; Julie A Schneider; David A Bennett; Patricia A Boyle
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  Residual decline in cognition after adjustment for common neuropathologic conditions.

Authors:  Lei Yu; Patricia A Boyle; Eisuke Segawa; Sue Leurgans; Julie A Schneider; Robert S Wilson; David A Bennett
Journal:  Neuropsychology       Date:  2014-12-15       Impact factor: 3.295

8.  Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia.

Authors:  Lei Yu; Vladislav A Petyuk; Chris Gaiteri; Sara Mostafavi; Tracy Young-Pearse; Raj C Shah; Aron S Buchman; Julie A Schneider; Paul D Piehowski; Ryan L Sontag; Thomas L Fillmore; Tujin Shi; Richard D Smith; Philip L De Jager; David A Bennett
Journal:  Ann Neurol       Date:  2018-07-03       Impact factor: 10.422

9.  In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies.

Authors:  Veronika Hanko; Alexandra C Apple; Kathryn I Alpert; Kristen N Warren; Julie A Schneider; Konstantinos Arfanakis; David A Bennett; Lei Wang
Journal:  Neurobiol Aging       Date:  2018-10-25       Impact factor: 4.673

10.  Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.

Authors:  Inger van Steenoven; Dag Aarsland; Daniel Weintraub; Elisabet Londos; Frédéric Blanc; Wiesje M van der Flier; Charlotte E Teunissen; Brit Mollenhauer; Tormod Fladby; Milica G Kramberger; Laura Bonanni; Afina W Lemstra
Journal:  J Alzheimers Dis       Date:  2016-08-18       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.